Ganvir Ophthalmic Gel
Marketer
Maa Enterprise
Salt Composition
Ganciclovir (0.15% w/w)
Overview Ganvir Ophthalmic Gel
Ganciclovir ophthalmic gel is an antiviral medication indicated for treating cytomegalovirus (CMV) infections in immunocompromised patients post-organ or bone marrow transplant. This gel helps prevent vision loss from CMV retinitis, a severe eye infection. For external ocular use only, apply as directed by your physician. Always wash hands before and after application. Gently squeeze the gel into the lower eyelid, avoiding contact with the applicator tip and the eye. Minor, transient eye irritation may occur post-application; persisting irritation should be reported. Contact lens wear is contraindicated during treatment.
Primary Ingredients of Ganvir Ophthalmic Gel
No text provided. Please provide the text you wish to be rephrased.
Uses of Ganvir Ophthalmic Gel
CMV Infection
Major Benefits of Ganvir Ophthalmic Gel:
Apply this medication externally only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Keep the applicator near, but not touching, the eye. Carefully dispense the medication into the lower eyelid sac by gently pressing the tube.
Common Side effects of Ganvir Ophthalmic Gel:
- Eye irritation
How to use Ganvir Ophthalmic Gel:
Apply this medication solely to the outer skin. Administer it according to your physician's prescribed dosage and timeframe. Always consult the product label for application instructions. Keep the applicator near, but not touching, the eye. Carefully dispense the medication into the lower eyelid sac.
How Ganvir Ophthalmic Gel works:
Ganvir Ophthalmic Gel combats viral eye infections with its antiviral properties. The gel's mechanism involves inhibiting viral replication on the cornea, thereby halting further viral spread and promoting the resolution of the infection.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Ganvir Ophthalmic Gel during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Ganvir Ophthalmic Gel while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Ganvir Ophthalmic Gel may induce adverse reactions impacting driving capabilities. These may include drowsiness, dizziness, confusion, tremors, loss of equilibrium, or seizures.
KidneyNone
No drug interactions identified.
LiverNone
No known drug interactions.
What if you forget to take Ganvir Ophthalmic Gel :
Should you forget a Ganvir Ophthalmic Gel application, administer it promptly. However, if your next scheduled dose is imminent, omit the missed application and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ganvir Ophthalmic Gel
Label | Value |
---|---|
Chemical Type | Nucleobase analog |
Developing Habits | No. |
Type of Therapy | Ophthalmology |
Action Class | Non-HIV antiviral medications |